Literature DB >> 8864219

A comparative study of the broth micro- and macro-dilution techniques for the determination of the in vitro susceptibility of Aspergillus fumigatus.

E K Manavathu1, G J Alangaden, S A Lerner.   

Abstract

The effects of inoculum size, medium, temperature, and duration of growth on the in vitro susceptibility testing of Aspergillus fumigatus were investigated using broth micro- and macro-dilution techniques. The minimum inhibitory concentrations (MICs) of ketoconazole, miconazole, itraconazole, fluconazole, and amphotericin B were significantly influenced by the inoculum size, regardless of the techniques used. Two- to four-fold higher MIC values were obtained when the inoculum size was increased 100-fold. The use of peptone yeast extract glucose and RPMI 1640 media provided essentially identical MIC values at 30 and 35 degrees C after incubation for 48 h or longer. A comparison of broth micro- and macro-dilution techniques revealed that, under equivalent conditions, the latter with an inoculum size between 1 x 10(3) and 1 x 10(4) conidia (strain W73355)/mL consistently provided the lowest MICs of fluconazole (256 micrograms/mL), ketoconazole (8 micrograms/mL), miconazole (2 micrograms/mL), itraconazole (0.25 micrograms/mL), and amphotericin B (0.25 micrograms/mL). Using the broth macrodilution technique we screened 24 clinical isolates of A. fumigatus obtained from the Detroit Medical Center in 1994. The MIC values of fluconazole, ketoconazole, miconazole, itraconazole and amphotericin B for all the isolates were 128-256, 8-16, 1-2, 0.25-0.5, and 0.25-1.0 micrograms/mL, respectively, indicating that none of the clinical isolates that we tested shows acquired resistance to the antifungals used.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864219     DOI: 10.1139/m96-123

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  7 in total

1.  Proton-pumping-ATPase-targeted antifungal activity of a novel conjugated styryl ketone.

Authors:  E K Manavathu; J R Dimmock; S C Vashishtha; P H Chandrasekar
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

Review 2.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

3.  Inhibition of RNA synthesis as a therapeutic strategy against Aspergillus and Fusarium: demonstration of in vitro synergy between rifabutin and amphotericin B.

Authors:  C J Clancy; Y C Yu; A Lewin; M H Nguyen
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

4.  Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides.

Authors:  E J Helmerhorst; I M Reijnders; W van't Hof; I Simoons-Smit; E C Veerman; A V Amerongen
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

5.  Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents.

Authors:  E K Manavathu; J Cutright; P H Chandrasekar
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

6.  Organism-dependent fungicidal activities of azoles.

Authors:  E K Manavathu; J L Cutright; P H Chandrasekar
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

7.  Inhibition realization of multidrug resistant bacterial and fungal isolates using Coccinia indica extracts.

Authors:  Mohammad Y Alshahrani; Essam H Ibrahim; Mohammed Asiri; Mona Kilany; Ahmad Alshehri; Ali G Alkhathami; Kareem Morsy; Harish C Chandramoorthy
Journal:  Saudi J Biol Sci       Date:  2022-01-24       Impact factor: 4.052

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.